Potential targeted therapy found for newly identified leukemia subtype with poor outcome

(St. Jude Children's Research Hospital) St. Jude Children's Research Hospital-led study expands understanding of the genetic basis of acute lymphoblastic leukemia subtypes and identifies possible targeted therapy for some patients at risk for a poor outcome.